Division of Endocrinology, Diabetes and Metabolism, Harvard Medical School and Harvard School of Public Health, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215, USA.
Eur J Endocrinol. 2011 Aug;165(2):249-54. doi: 10.1530/EJE-11-0252. Epub 2011 May 20.
Short-term energy deprivation reduces leptin concentrations and alters the levels of circulating hormones of the hypothalamic-pituitary-peripheral axis in lean subjects. Whether the reduction in leptin concentration during long-term weight loss in obese individuals is linked to the same neuroendocrine changes seen in lean, leptin-sensitive subjects remains to be fully clarified.
In this study, 24 overweight and obese adults (16 women and eight men; body mass index (BMI): 27.5-38.0 kg/m(2)) were prescribed a hypocaloric diet (-500 kcal/day) and were randomized to receive recombinant methionyl leptin (n=18, metreleptin, 10 mg/day self-injected s.c.) or placebo (n=6, same volume and time as metreleptin) for 6 months.
Metreleptin administration did not affect weight loss beyond that induced by hypocaloric diet alone (P for interaction=0.341) but increased the serum concentrations of total leptin by six- to eight-fold (P<0.001) and led to the generation of anti-leptin antibodies. Despite free leptin concentration (P for interaction=0.041) increasing from 9±1 ng/ml at baseline to 43±15 and 36±12 ng/ml at 3 and 6 months, respectively, changes in circulating hormones of the thyroid and IGF axes at 3 and 6 months were not significantly different in the placebo- and metreleptin-treated groups.
Leptin does not likely mediate changes in neuroendocrine function in response to weight loss induced by a mild hypocaloric diet in overweight and obese subjects.
短期能量剥夺可降低瘦素浓度,并改变瘦素敏感受试者下丘脑-垂体-外周轴中环流激素的水平。肥胖个体长期减肥过程中瘦素浓度的降低是否与瘦素敏感受试者中所见的相同神经内分泌变化有关,仍有待充分阐明。
本研究纳入 24 名超重和肥胖成年人(16 名女性和 8 名男性;体重指数(BMI):27.5-38.0kg/m²),给予低热量饮食(-500kcal/天),并随机分为接受重组甲硫氨酸瘦素(n=18,metreleptin,10mg/天皮下注射)或安慰剂(n=6,与 metreleptin 相同的体积和时间)治疗 6 个月。
metreleptin 治疗并未增加低热量饮食单独诱导的体重减轻(交互作用 P=0.341),但使总瘦素血清浓度增加 6-8 倍(P<0.001),并导致抗瘦素抗体的产生。尽管游离瘦素浓度(交互作用 P=0.041)从基线时的 9±1ng/ml 分别增加至 3 个月时的 43±15ng/ml 和 6 个月时的 36±12ng/ml,但在安慰剂和 metreleptin 治疗组中,甲状腺和 IGF 轴中环流激素的变化在 3 个月和 6 个月时并无显著差异。
在超重和肥胖个体中,瘦素不太可能介导轻度低热量饮食诱导的体重减轻对神经内分泌功能的变化。